Landscape → Metabolic

Dyslipidemia

447 clinical trials

90 active

447 total (since 2015)

Phase 1 Active

138 total

Phase 2 Active

100 total

Phase 3 Active

166 total

Phase 4 Active

62 total

Top Sponsors (Industry)

Sorted by active Active Done Failed

Addpharma Inc. 6 8 0

Novartis 5 11 0

Qilu Pharmaceutical Co., Ltd. 5 0 0

Merck 3 6 0

Arrowhead Pharmaceuticals 3 4 0

Beijing Suncadia Pharmaceuticals Co., Ltd 3 3 0

LIB Therapeutics LLC 2 7 0

JW Pharmaceutical 2 3 0

Shandong Suncadia Medicine Co., Ltd. 2 2 0

CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. 2 1 0

Verve Therapeutics, Inc. 2 1 0

Fujian Shengdi Pharmaceutical Co., Ltd. 2 1 0

Hasten Biopharmaceutical Co., Ltd. 2 0 0

AstraZeneca 1 9 1

Regeneron 1 8 1

NCT07450378 NOT YET RECRUITING

QLC7401 in Participants With Heterozygous Familial Hypercholesterolemia (HeFH)

Qilu Pharmaceutical Co., Ltd. n=120

NCT07441317 NOT YET RECRUITING

QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated Low Density Lipoprotein Cholesterol (LDL-C)

Qilu Pharmaceutical Co., Ltd. n=780

NCT07444086 NOT YET RECRUITING

QLC7401 Monotherapy in Non-familial Hypercholesterolemia or Mixed Dyslipidemia

Qilu Pharmaceutical Co., Ltd. n=510

NCT07216482 RECRUITING

A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037)

Merck Sharp & Dohme LLC n=975

NCT07421297 NOT YET RECRUITING

A Study to Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholesterolemia or Mixed Hyperlipidemia

CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. n=760

NCT06597006 RECRUITING

Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia

Novartis Pharmaceuticals n=9

NCT07421284 NOT YET RECRUITING

A Study to Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia on a Background of Lipid-lowering Therapy

CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. n=900

NCT07058077 RECRUITING

A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)

Merck Sharp & Dohme LLC n=153

NCT07037771 RECRUITING

A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE)

Arrowhead Pharmaceuticals n=60

NCT07404553 NOT YET RECRUITING

A Study Of SHR-1918 In Participants With Hypercholesterolemia With Inadequate Lipid Control on Statins Plus PCSK9 Inhibitors

Beijing Suncadia Pharmaceuticals Co., Ltd n=126

NCT05682378 ACTIVE NOT RECRUITING

Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Adolescent ORION-16 or ORION-13 Studies

Novartis Pharmaceuticals n=131

NCT07230730 RECRUITING

A Trial to Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia

Beijing Suncadia Pharmaceuticals Co., Ltd n=900

NCT05238519 ACTIVE NOT RECRUITING

Improved Diagnosis of Familial Hypercholesterolemia Across the Northland (ID-FH)

Essentia Health n=300

NCT06772168 RECRUITING

Evaluate the Efficacy and Safety of CMG190303 in Patients With Type 2 Diabetes and Dyslipidemia

CMG Pharmaceutical Co. Ltd n=240

NCT04765657 ACTIVE NOT RECRUITING

Study of Efficacy and Safety of Inclisiran in Asian Participants With Atherosclerotic Cardiovascular Disease (ASCVD) or ASCVD High Risk and Elevated Low Density Lipoprotein Cholesterol (LDL-C)

Novartis Pharmaceuticals n=345

NCT06597019 RECRUITING

Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia

Novartis Pharmaceuticals n=51

NCT06492291 ACTIVE NOT RECRUITING

Open-label Extension Study of Enlicitide Decanoate (MK-0616/Enlicitide Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-019) CORALreef Extension

Merck Sharp & Dohme LLC n=3,000

NCT06643130 RECRUITING

Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients With Hypertension and Dyslipidemia

JW Pharmaceutical n=162

NCT07102511 NOT YET RECRUITING

Randomized, Placebo-Controlled, Double-Blind, Phase 3b Study to Evaluate the Efficacy and Safety of Lerodalcibep in Children 6 to 17 Years, With Heterozygous FH

LIB Therapeutics LLC n=150

NCT06568471 RECRUITING

A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia

Hasten Biopharmaceutical Co., Ltd. n=210

NCT05400317 RECRUITING

A Study to Evaluate the Efficacy and Safety of AD-218

Addpharma Inc. n=520

NCT06747936 NOT YET RECRUITING

A Study to Evaluate the Efficacy and Safety of Co-administration of AD-2281 and AD-2282

Addpharma Inc. n=110

NCT06782646 ENROLLING BY INVITATION

Study on the Sex-specific, Lipid- and Lipoprotein-lowering Effects of Berberine

The University of Hong Kong n=100

NCT06780410 RECRUITING

A Clinical Study to Evaluate the Efficacy, Tolerability, and Safety of Bempedoic Acid

Gan & Lee Pharmaceuticals. n=240

NCT06717360 NOT YET RECRUITING

A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of AG2304T and AG2304R

Ahn-Gook Pharmaceuticals Co.,Ltd n=140

NCT06712771 NOT YET RECRUITING

A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of VSA003 in Chinese HoFH Patients

Visirna Therapeutics HK Limited n=45

NCT04798430 ENROLLING BY INVITATION

Long-term Efficacy and Safety of OLE LIB003 in HoFH, HeFH, and High-risk CVD Patients Requiring Further LDL-C Reduction

LIB Therapeutics LLC n=2,000

NCT05621070 RECRUITING

Efficacy and Safety of JS002 as Monotherapy in Patients With Primary Hypercholesterolaemia and Mixed Dyslipidemia

Shanghai Junshi Bioscience Co., Ltd. n=582

NCT02726555 RECRUITING

The Efficacy and Safety of Combined Therapy With Red Yeast Rice and Low-dose Statin：Comparing With Standardized Statin

Wenzhou Medical University n=240

NCT06220266 RECRUITING

Effects of Phytoestrogen From Pueraria Mirifica in Improvement of Serum Lipid Parameters in Postmenopausal Women

Dhurakij Pundit University n=10

NCT07444762 COMPLETED

Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of DW5421A/DW5421B Compared to Monotherapy of DW5421A

Daewon Pharmaceutical Co., Ltd. n=184

NCT05952869 COMPLETED

A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Heterozygous Familial Hypercholesterolemia (MK-0616-017/CORALreef HeFH)

Merck Sharp & Dohme LLC n=303

NCT04652726 COMPLETED

Study to Evaluate Efficacy and Safety of Inclisiran in Adolescents With Heterozygous Familial Hypercholesterolemia

Novartis Pharmaceuticals n=141

NCT04659863 COMPLETED

Study to Evaluate Efficacy and Safety of Inclisiran in Adolescents With Homozygous Familial Hypercholesterolemia

Novartis Pharmaceuticals n=13

NCT05888103 COMPLETED

Efficacy and Safety of Inclisiran as Monotherapy in Chinese Adults With Low or Moderate ASCVD Risk and Elevated Low-density Lipoprotein Cholesterol.

Novartis Pharmaceuticals n=207

NCT03540355 COMPLETED

Efficacy and Safety of Cipros 20 Association on Dyslipidemia Treatment

EMS n=406

NCT03207945 COMPLETED

Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study)

University of California, San Francisco n=118

NCT07295418 COMPLETED

A Study of SAL003 in Participants With Hypercholesterolemia and Mixed Dyslipidemia

Shenzhen Salubris Pharmaceuticals Co., Ltd. n=618

NCT06723652 COMPLETED

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia

Beijing Suncadia Pharmaceuticals Co., Ltd n=55

NCT05923281 COMPLETED

A Phase III Confirmatory Study of K-877 (Pemafibrate) in Patients With Hypercholesterolemia and Statin Intolerance

Kowa Company, Ltd. n=71

NCT03527069 COMPLETED

Efficacy and Safety of Cipros 10 Association on the Isolated Hypertriglyceridemia and Dyslipidemia Treatment

EMS n=146

NCT07253584 COMPLETED

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Safety and Efficacy of SAL003 in Combination With Statin Therapy in Patients With Hypercholesterolemia and Mixed Dyslipidemia

Shenzhen Salubris Pharmaceuticals Co., Ltd. n=720

NCT06165250 COMPLETED

A Study to Evaluate the Efficacy and Safety of Co-administrated BR1018B and BR1018C

Boryung Pharmaceutical Co., Ltd n=156

NCT04716595 COMPLETED

A Phase III Long Term Study of K-877 Extended Release Tablet

Kowa Company, Ltd. n=121

NCT05763875 COMPLETED

Efficacy and Safety of Inclisiran as Monotherapy in Patients With Primary Hypercholesterolemia Not Receiving Lipid-lowering Therapy.

Novartis Pharmaceuticals n=350

NCT06005597 COMPLETED

Study of Obicetrapib & Ezetimibe Fixed Dose Combination on Top of Maximum Tolerated Lipid-Modifying Therapies

NewAmsterdam Pharma n=407

NCT03071692 TERMINATED

Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)

Kowa Research Institute, Inc. n=10,544

NCT04669041 COMPLETED

A Study to Evaluate the Efficacy and the Safety of Single Pill Combination (SPC) Ezetimibe/Rosuvastatin in Chinese Adult Patients With Primary Hypercholesterolemia Not Adequately Controlled on Statin Therapy

Sanofi n=305

NCT05142722 COMPLETED

Randomized Study to Evaluate the Effect of Obicetrapib on Top of Maximum Tolerated Lipid-Modifying Therapies

NewAmsterdam Pharma n=2,530

NCT05952856 COMPLETED

A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-013) CORALreef Lipids

Merck Sharp & Dohme LLC n=2,912

NCT06955104 COMPLETED

Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of JW0108+C2407 in Patients With Dyslipidemia

JW Pharmaceutical n=145

NCT05425745 COMPLETED

Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies.

NewAmsterdam Pharma n=354

NCT04998981 COMPLETED

A Phase 3 Study to Evaluate the Efficacy and Safety of K-877 in Chinese Patients With High TG and Low HDL-C

Kowa Company, Ltd. n=353

NCT06450366 COMPLETED

A Study to Evaluate the Efficacy and Safety of Enlicitide Decanoate (MK-0616, Oral PCSK9 Inhibitor) Compared With Ezetimibe or Bempedoic Acid or Ezetimibe and Bempedoic Acid in Adults With Hypercholesterolemia (MK-0616-018) CORALreef AddOn

Merck Sharp & Dohme LLC n=301

NCT03409744 COMPLETED

Evaluate the Long-Term Safety and Efficacy of Evinacumab in Patients With Homozygous Familial Hypercholesterolemia

Regeneron Pharmaceuticals n=116

NCT05611528 COMPLETED

Safety and Effectiveness of Evinacumab for the Treatment of Homozygous Familial Hypercholesterolemia

Daniel Gaudet n=10

NCT06276205 COMPLETED

Vitamin D & Levothyroxine Combination Versus Levothyroxine on Lipid Profile in Hypothyroidism

King Edward Medical University n=62

NCT05255094 COMPLETED

A Study to Evaluate the Efficacy and Safety of AK102 in Patients With Hyperlipidemia

Akeso n=464

NCT05260411 COMPLETED

A Study to Evaluate the Efficacy and Safety of AK102 Q6W in Patients With Hyperlipidemia

Akeso n=246

NCT05255458 COMPLETED

A Study to Evaluate the Long-term Efficacy and Safety of AK102 in Patients With Hyperlipidemia

Akeso n=122

NCT04709536 COMPLETED

A Study of IBI306 in Participants With Hypercholesterolemia

Innovent Biologics (Suzhou) Co. Ltd. n=306

NCT04964544 COMPLETED

Technology-Assisted Cholesterol Trial in Consumers (TACTiC)

AstraZeneca n=1,196

NCT05809687 WITHDRAWN

Phase 3 Trial to Evaluate the Efficacy and Safety of DKP21102_B Added on to DKP21102_A Compared With DKP21102_A

Dongkwang Pharm. Co., Ltd.

NCT05004675 COMPLETED

Trial to Evaluate Efficacy and Safety of LIB003 and Inclisiran in High-risk CVD Patients

LIB Therapeutics LLC n=166

NCT05930028 COMPLETED

A Study to Evaluate the Efficacy and Safety of BR1017A and BR1017B Combination Therapy in Essential Hypertension Patients With Primary Hypercholesterolemia

Boryung Pharmaceutical Co., Ltd n=148

NCT03689946 COMPLETED

Effect of Evolocumab on Coronary Atherosclerosis

Cedars-Sinai Medical Center n=55

NCT04233918 COMPLETED

Evaluate the Efficacy and Safety of Evinacumab in Pediatric Patients With Homozygous Familial Hypercholesterolemia

Regeneron Pharmaceuticals n=20

NCT02956590 COMPLETED

Dyslipidemia of Obesity Intervention in Teens

Carelon Research n=122

NCT04714151 COMPLETED

A Phase III Confirmatory Study of K-877 Extended Release Tablet

Kowa Company, Ltd. n=356

NCT06448962 COMPLETED

Phase 3 Study to Evaluate the Efficacy and Safety of Co-administrated AD-2021 and AD-2022

Addpharma Inc. n=109

NCT02624869 COMPLETED

Safety, Tolerability and Efficacy of Evolocumab (AMG 145) in Children With Inherited Elevated Low-density Lipoprotein Cholesterol (Familial Hypercholesterolemia)

Amgen n=163

NCT03080935 TERMINATED

Fourier Open-label Extension Study in Subjects With Clinically Evident Cardiovascular Disease in Selected European Countries

Amgen n=1,600

NCT02550288 COMPLETED

A Clinical Trial to Assess the Efficacy and Safety of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-383)

Organon and Co n=309

NCT02741245 COMPLETED

A Study of the Efficacy and Safety of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-832)

Organon and Co n=321

NCT02460159 COMPLETED

A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-384)

Organon and Co n=135

NCT03768427 COMPLETED

Ezetimibe (EZ)/Atorvastatin (Ator) (MK-0653C) vs. Ator in Chinese Hypercholesterolemic Participants (MK-0653C-439)

Organon and Co n=454

NCT02748057 COMPLETED

A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-833)

Organon and Co n=135

NCT05325203 COMPLETED

A Study to Evaluate the Efficacy and Safety of JS002 in Patients With Heterozygous Familial Hypercholesterolemia (HeFH).

Shanghai Junshi Bioscience Co., Ltd. n=135

NCT05331014 COMPLETED

To Evaluate the Efficacy and Safety in Patients With Dyslipidemia and Hypertension

JW Pharmaceutical n=155

NCT03814187 COMPLETED

Trial to Assess the Effect of Long Term Dosing of Inclisiran in Subjects With High CV Risk and Elevated LDL-C

Novartis Pharmaceuticals n=3,275

NCT04885218 COMPLETED

Efficacy and Safety of SHR-1209 Combined With Lipid-lowering Agents in Patients With Hypercholesterolemia

Jiangsu HengRui Medicine Co., Ltd. n=692

NCT04797104 COMPLETED

Study to Assess the Efficacy and Safety of LIB003 in HeFH Patients on Oral Lipid Therapy Needing Further LDL-C Reduction

LIB Therapeutics LLC n=478

NCT04289662 COMPLETED

K-924 Phase III Long Term Study

Kowa Company, Ltd. n=110

NCT04289649 COMPLETED

K-924 Phase III Confirmatory Study

Kowa Company, Ltd. n=293

NCT04591808 TERMINATED

Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia

Institut de Recherches Internationales Servier n=146

NCT04179669 COMPLETED

Safety and Efficacy of IBI306 in HeFH Patients

Innovent Biologics (Suzhou) Co. Ltd. n=149

NCT04031742 COMPLETED

A Study to Evaluate Safety and Efficacy of IBI306, a PCSK9 Monoclonal Antibody in Chinese Subjects With Homozygous Familial Hypercholesterolemia

Innovent Biologics (Suzhou) Co. Ltd. n=18

NCT05970679 COMPLETED

Clinical Trial to Evaluate the Efficacy and Safety of DW1125 and DW1125A

Daewon Pharmaceutical Co., Ltd. n=252

NCT02947620 COMPLETED

Metformin/Atorvastatin Combination Therapy in Subjects With Type II Diabetes and Dyslipidemia (Phase 3)

Daewoong Pharmaceutical Co. LTD. n=185

NCT04849000 COMPLETED

Study of SHR-1209 in the Treatment of Hypercholesterolemia and Hyperlipidemia Ⅲ Stage

Jiangsu HengRui Medicine Co., Ltd. n=709

NCT04844125 COMPLETED

SHR - 1209 Treatment Efficacy and Safety of the Patients With Hypercholesterolemia Ⅲ Period Clinical Research

Jiangsu HengRui Medicine Co., Ltd. n=144

NCT02867813 COMPLETED

Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk Open-label Extension

Amgen n=5,035

NCT04790513 COMPLETED

Trial to Evaluate Efficacy and Safety of LIB003, Evolocumab and Alirocumab in High-risk CVD Patients

LIB Therapeutics LLC n=204

NCT04034485 COMPLETED

Phase 3 Study to Evaluate the Efficacy and Safety of LIB003 With Evolocumab in HoFH

LIB Therapeutics LLC n=65

NCT03433755 TERMINATED

Safety and Efficacy of Evolocumab in Addition to Optimal Stable Background Statin Therapy in Chinese Participants With Primary Hypercholesterolemia and Mixed Dyslipidemia

Amgen n=259

NCT05742022 COMPLETED

"Phospholipovit" vs Placebo in Patients With Combined Hyperlipidemia

Institute of Biomedical Chemistry, Russia n=100

NCT03851705 COMPLETED

A Study of Inclisiran in Participants With Homozygous Familial Hypercholesterolemia (HoFH)

Novartis Pharmaceuticals n=56

NCT02585895 COMPLETED

Evolocumab Compared to LDL-C Apheresis in Patients Receiving LDL-C Apheresis Prior to Study Enrollment

Amgen n=39

NCT02392559 COMPLETED

Trial Assessing Efficacy, Safety and Tolerability of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition in Paediatric Subjects With Genetic Low-Density Lipoprotein (LDL) Disorders

Amgen n=158

NCT04886297 COMPLETED

A Dose-response Study of Dietary Resveratrol on Lipid Metabolism Disorder

Sun Yat-sen University n=168

NCT02729025 COMPLETED

Effects of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition on Arterial Wall Inflammation in Patients With Elevated Lipoprotein(a) (Lp(a))

Amgen n=129

NCT02833844 COMPLETED

Safety, Tolerability and Efficacy on Low Density Lipoprotein Cholesterol (LDL-C) of Evolocumab in Participants With Human Immunodeficiency Virus (HIV) and Hyperlipidemia/Mixed Dyslipidemia

Amgen n=467

NCT05131997 COMPLETED

A Study to Evaluate the Efficacy and Safety of AD-221 and AD-221A

Addpharma Inc. n=290

NCT05234775 COMPLETED

Cross-Over Study to Compare the Pharmacokinetics and Pharmacodynamics of LIB003 Process 1 and Process 2 Drug Product

LIB Therapeutics LLC n=22

NCT03422666 COMPLETED

Plasma Lipoprotein Response to Glucagon-like Peptide-2

University Health Network, Toronto n=10

NCT03442972 COMPLETED

Glucagon-like Peptide-2 Mediated Secretion of Stored Enteral Lipids

University Health Network, Toronto n=21

NCT04643093 COMPLETED

Compare the Efficacy and Safety of 1PC111 With Pitavastatin and Ezetimibe in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

Orient Pharma Co., Ltd. n=390

NCT04289285 COMPLETED

Safety and Efficacy of IBI306 in Chinese Subjects With Non-familial Hypercholesterolemia

Innovent Biologics (Suzhou) Co. Ltd. n=804

NCT02476006 COMPLETED

Safety, Tolerability, and Effect of Alirocumab in High Cardiovascular Risk Patients With Severe Hypercholesterolemia Not Adequately Controlled With Conventional Lipid-modifying Therapies (ODYSSEY APPRISE)

Sanofi n=998

NCT03009487 COMPLETED

A Clinical Trial to Evaluate the Efficacy and Safety of Olmesartan/Amlodipine/Rosuvastatin Combination Treatment in Patients With Concomitant Hypertension and Hyperlipidemia

Daewoong Pharmaceutical Co. LTD. n=265

NCT04584736 COMPLETED

To Evaluate the Efficacy and Safety in Patients With Primary Hypercholesterolemia

JW Pharmaceutical n=283

NCT04312698 COMPLETED

Clinical Trial to Evaluate the Efficacy and Safety of CKD-386

Chong Kun Dang Pharmaceutical n=100

NCT03156621 COMPLETED

Study in Participants With Homozygous Familial Hypercholesterolemia (HoFH)

Regeneron Pharmaceuticals n=69

NCT03399786 COMPLETED

Efficacy and Safety of Evinacumab in Patients With Homozygous Familial Hypercholesterolemia

Regeneron Pharmaceuticals n=65

NCT04158076 COMPLETED

Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan/Amlodipine

Addpharma Inc. n=131

NCT02670434 WITHDRAWN

Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia

Kowa Research Institute, Inc.

NCT02799758 WITHDRAWN

Efficacy & Long-term Safety Comparison Study of NK-104-CR & Livalo® IR With Primary Hyperlipidemia or Mixed Dyslipidemia

Kowa Research Institute, Inc.

NCT04652349 COMPLETED

Efficacy and Safety of HGP1910 and HCP1903 in Patients With Primary Hypercholesterolemia

Hanmi Pharmaceutical Company Limited n=279

NCT03067441 COMPLETED

Assessment of the Long-Term Safety and Efficacy of Bempedoic Acid (CLEAR Harmony OLE)

Esperion Therapeutics, Inc. n=1,462

NCT02662894 WITHDRAWN

Fixed-dose Combination of Valsartan + Rosuvastatin Versus Their Isolated Components for Hypertension and Dyslipidemia.

EMS

NCT03872232 COMPLETED

Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan

Addpharma Inc. n=180

NCT03510715 COMPLETED

An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia

Sanofi n=18

NCT04074551 COMPLETED

A Phase 3 Study to Compare the Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and Dyslipidemia

Hanmi Pharmaceutical Company Limited n=145

NCT02634580 COMPLETED

Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-4

Amgen n=61

NCT03415503 COMPLETED

Dietary Anthocyanins Improve Lipid Metabolism in a Dose - Dependent Manner

Sun Yat-sen University n=169

NCT03397121 COMPLETED

Trial to Evaluate the Effect of Inclisiran Treatment on Low Density Lipoprotein Cholesterol (LDL-C) in Subjects With Heterozygous Familial Hypercholesterolemia (HeFH)

The Medicines Company n=482

NCT02666664 COMPLETED

Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk (CLEAR Harmony)

Esperion Therapeutics, Inc. n=2,230

NCT03001076 COMPLETED

Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) as Add-on to Ezetimibe Therapy in Patients With Elevated LDL-C (CLEAR Tranquility)

Esperion Therapeutics, Inc. n=269

NCT02326220 COMPLETED

Study of Alirocumab (REGN727/SAR236553) in Patients With Heterozygous Familial Hypercholesterolemia (HeFH) Undergoing Low-density Lipoprotein (LDL) Apheresis Therapy

Regeneron Pharmaceuticals n=62

NCT02991118 COMPLETED

Evaluation of Long-Term Efficacy of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia at High Cardiovascular Risk

Esperion Therapeutics, Inc. n=779

NCT03337308 COMPLETED

A Study Evaluating the Safety and Efficacy of Bempedoic Acid Plus Ezetimibe Fixed-Dose Combination Compared to Bempedoic Acid, Ezetimibe, and Placebo in Patients Treated With Maximally Tolerated Statin Therapy

Esperion Therapeutics, Inc. n=382

NCT02988115 COMPLETED

Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia and Statin Intolerant

Esperion Therapeutics, Inc. n=345

NCT03534661 COMPLETED

L-NMMA on GLP-2 Mediated Intestinal Lipoprotein Release

University Health Network, Toronto n=10

NCT02715726 COMPLETED

Evaluation of Alirocumab Versus Ezetimibe on Top of Statin in Asia in High Cardiovascular Risk Patients With Hypercholesterolemia

Sanofi n=615

NCT03583905 COMPLETED

Clinical Trial to Evaluate the Efficacy and Safety of CKD-333 Tablet

Chong Kun Dang Pharmaceutical n=154

NCT02455336 COMPLETED

Fenofibrate Treatment in SCI

VA Office of Research and Development n=23

NCT02524106 TERMINATED

Bococizumab HIV Evaluation (B-HIVE) Study

University of California, San Francisco n=11

NCT03156842 COMPLETED

Combination of Fimasartan/Amlodipine/Rosuvastatin in Patients With Essential Hypertension and Dyslipidemia

Boryung Pharmaceutical Co., Ltd n=138

NCT02584504 COMPLETED

Efficacy and Safety of Alirocumab in Patients With Hypercholesterolemia Not Adequately Controlled With Non-statin Lipid Modifying Therapy or the Lowest Strength of Statin

Sanofi n=163

NCT03067688 COMPLETED

Clinical Trial of Temisartan/Amlodipine & Rosuvastatin in Subjects With Hypertension and Hyperlipidemia

Yuhan Corporation n=202

NCT02662569 COMPLETED

Safety and Efficacy of Evolocumab in Combination With Statin Therapy in Adults With Diabetes and Hyperlipidemia or Mixed Dyslipidemia

Amgen n=986

NCT03482180 COMPLETED

Evaluate the Efficacy and Safety of KI1106 in Patients Whose TG Level is Not Adequately Controlled With Atorvastatin Calcium Monotherapy While LDL-C is Properly Controlled

Kuhnil Pharmaceutical Co., Ltd. n=215

NCT03433196 COMPLETED

Efficacy and Safety Study of the HS-25 Combination With Atorvastatin in Subjects With Hypercholesterolemia in Coronary Heart Diseases

Zhejiang Hisun Pharmaceutical Co. Ltd. n=255

NCT03413462 COMPLETED

Efficacy and Safety Study of HS-25 in Chinese Adults With Primary Hypercholesterolemia

Zhejiang Hisun Pharmaceutical Co. Ltd. n=374

NCT02260648 TERMINATED

A Study of Evacetrapib (LY2484595) in Combination With Atorvastatin in Japanese Participants With Primary Hypercholesterolemia

Eli Lilly and Company n=149

NCT02586129 COMPLETED

Clinical Trial of YH14755 in Subjects With Dyslipidemia and Type II Diabetes

Yuhan Corporation n=249

NCT03103256 COMPLETED

Clinical Trial to Evaluate the Efficacy and Safety of YHP1701

Yuhan Corporation n=106

NCT02739984 COMPLETED

Evaluation of Evolocumab (AMG 145) Efficacy in Diabetic Adults With Hypercholesterolemia/Mixed Dyslipidemia

Amgen n=424

NCT03618797 COMPLETED

A Clinical Trial to Evaluate the Efficacy and Safety of Pitavastatin/Fenofibrate in Complex-dyslipidemia

Hanlim Pharm. Co., Ltd. n=347

NCT02827903 COMPLETED

Metformin/Rosuvastatin Combination Therapy With in Patients With Type 2 Diabetes and Dyslipidemia

Jeil Pharmaceutical Co., Ltd. n=237

NCT03088254 COMPLETED

Study to Evaluate the Efficacy and Safety of Telmisartan/Amlodipine/Rosuvastatin

Jeil Pharmaceutical Co., Ltd. n=126

NCT03566316 COMPLETED

Efficacy/Safety of Telmisartan/Amlodipine/Rosuvastatin in Hypertensive Patients With Hyperlipidemia

IlDong Pharmaceutical Co Ltd n=134

NCT02749994 COMPLETED

A Clinical Trial to Compare the Efficacy and Safety of a Combination Therapy of Ezetimibe and Rosuvastatin Versus Monotherapy of Rosuvastatin in Hypercholesterolemia Patients (I-ROSETTE Study)

IlDong Pharmaceutical Co Ltd n=396

NCT03536598 COMPLETED

Study to Evaluate the Safety and Efficacy of CJ-30060 in Hypertensive Patients With Hyperlipidemia

HK inno.N Corporation n=203

NCT02434497 COMPLETED

A Study to Evaluate the Safety of Rosuvastatin in Children and Adolescents With Homozygous Familial Hypercholesterolemia

AstraZeneca n=9

NCT02765841 WITHDRAWN

Evaluate the Efficacy and Safety of Lomitapide in Pediatric Patients With Homozygous Familial Hypercholesterolemia on Stable Lipid-lowering Therapy

Aegerion Pharmaceuticals, Inc.

NCT03429998 COMPLETED

Evolocumab Versus LDL Apheresis in Patients With Hypercholesterolemia

Hospital General Universitario Gregorio Marañon n=9

NCT03210532 COMPLETED

Evaluate the Efficacy and Safety of Combination Treatment With DW1501-R1+DW1501-R2 Versus DW1501-R1 or DW1501-R2+DW1501-R3 in Patients With Hypertension and Dyslipidemia

Daewon Pharmaceutical Co., Ltd. n=129

NCT02458287 COMPLETED

Efficacy, Safety, Tolerability And Actual Use Study Of Bococizumab And An Autoinjector (Pre-Filled Pen) In Subjects With Hyperlipidemia Or Dyslipidemia

Pfizer n=299

NCT02947334 WITHDRAWN

Efficacy And Safety Of Bococizumab For Lipid Lowering In Asian Hypercholesterolemia Subjects

Pfizer

NCT02289963 COMPLETED

Evaluation of Alirocumab in Addition to Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia in South Korea and Taiwan

Sanofi n=199

NCT02407548 COMPLETED

The Effects of Dietary Supplement of Coenzyme Q10（CoQ10） on Dyslipidemia

Sun Yat-sen University n=150

NCT02955368 WITHDRAWN

Clinical Trial to Evaluate the Efficacy and Safety of DP-R212

Alvogen Korea

NCT03141827 COMPLETED

The Effect of Intranasal Insulin on Hepatic and Intestinal Triglyceride-rich Lipoprotein Production

University Health Network, Toronto n=9

NCT02451098 COMPLETED

Clinical Trial to Evaluate the Efficacy and Safety of CKD-391

Chong Kun Dang Pharmaceutical n=385

NCT02609295 COMPLETED

Effects of α-linolenic Acid Supplementation on Hemostasis in Nondiabetic and Hypercholesterolemic Subjects

Yonsei University n=86

NCT07447206 NOT YET RECRUITING

Vascular Intervention Strategies Trial for Alzheimer's

University of Southern California

NCT06488105 RECRUITING

Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial

Wake Forest University Health Sciences

NCT07391722 NOT YET RECRUITING

DNV001 Injection in Patients With Hypercholesterolemia

Hangzhou Dinovate Biotech Co., Ltd

NCT04941599 RECRUITING

2-Hydroxybenzylamine (2-HOBA) to Reduce HDL Modification and Improve HDL Function in Familial Hypercholesterolemia (FH)

Vanderbilt University Medical Center

NCT06497127 ACTIVE NOT RECRUITING

A Study in Patients With Mixed Dyslipidemia

Shanghai Argo Biopharmaceutical Co., Ltd.

NCT07223658 RECRUITING

Study of ARO-DIMERPA in Adult Participants With Mixed Hyperlipidemia

Arrowhead Pharmaceuticals

NCT05488431 RECRUITING

Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)

Priscilla Hsue, MD

NCT07229937 RECRUITING

A Phase II Study To Evaluate the Efficacy And Safety Of HRS-1301 In Participants With Dyslipidemia

Shandong Suncadia Medicine Co., Ltd.

NCT04128969 ACTIVE NOT RECRUITING

Causal Mechanisms in Adolescent Arterial Stiffness

Baylor College of Medicine

NCT06822946 RECRUITING

Zhibitai Capsules for the Treatment of Primary Hyperlipidemia

Chengdu Diao Jiuhong Pharmaceutical Factory

NCT05217667 ACTIVE NOT RECRUITING

Study of ARO-ANG3 in Participants With Homozygous Familial Hypercholesterolemia (HOFH)

Arrowhead Pharmaceuticals

NCT06369571 ENROLLING BY INVITATION

Improving Cardiovascular Health Risks in Adults With Epilepsy on a Modified Atkins Diet

Johns Hopkins University

NCT06094491 ACTIVE NOT RECRUITING

Virtual Diabetes Group Visits Across Health Systems

University of Chicago

NCT07100418 RECRUITING

A Clinical Study Evaluating the Efficacy and Safety of HRS-7249 in Treating Patients With Hyperlipidemia

Fujian Shengdi Pharmaceutical Co., Ltd.

NCT06797401 RECRUITING

Phase 2 Trial Evaluating the Efficacy and Safety of RBD5044 in Patients With Mixed Dyslipidemia

Ribocure Pharmaceuticals AB

NCT07133815 NOT YET RECRUITING

Evaluate the Long-term Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia

Beijing Suncadia Pharmaceuticals Co., Ltd

NCT06496243 RECRUITING

Impact of Obicetrapib and Obicetrapib Plus Repatha on Lp(a) Levels

NewAmsterdam Pharma

NCT06750341 NOT YET RECRUITING

Study of QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated LDL Cholesterol

Qilu Pharmaceutical Co., Ltd.

NCT06703788 RECRUITING

Integrated Traditional Chinese Medicine Day Care Program for Metabolic Syndrome

Chang Gung Memorial Hospital

NCT06700408 NOT YET RECRUITING

RCT for the Chinese Medicine in Treating Hypercholesterolemia

Chinese University of Hong Kong

NCT06503172 RECRUITING

Whole Grain Job's Tear, Muscle Health, Blood Glucose and Lipid Level

Taipei Veterans General Hospital, Taiwan

NCT06422650 RECRUITING

Effect of Nigella Sativa in Atorvastatin Treated Hyperlipidaemia

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

NCT04998201 COMPLETED

Study of Plozasiran (ARO-APOC3) in Adults With Mixed Dyslipidemia

Arrowhead Pharmaceuticals

NCT07421232 COMPLETED

A Study to Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia

CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.

NCT06471218 COMPLETED

Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia

Beijing Suncadia Pharmaceuticals Co., Ltd

NCT03038022 COMPLETED

Study of MGL-3196 in Patients With Heterozygous Familial Hypercholesterolemia (HeFH)

Madrigal Pharmaceuticals, Inc.

NCT05413135 COMPLETED

Study of ARO-APOC3 in Adults With Dyslipidemia

Arrowhead Pharmaceuticals

NCT07278830 COMPLETED

A Phase II Study to Evaluate the Safety and Efficacy of SAL003 Combined With Atorvastatin in Hypercholesterolemia and Mixed Dyslipidemia

Shenzhen Salubris Pharmaceuticals Co., Ltd.

NCT04832971 COMPLETED

Study of ARO-ANG3 in Adults With Mixed Dyslipidemia

Arrowhead Pharmaceuticals

NCT06173570 COMPLETED

A Study to Assess the Efficacy, Safety and Tolerability of Different Doses of AZD0780 in Patients With Dyslipidemia

AstraZeneca

NCT04079530 COMPLETED

A Clinical Pharmacology Study of K-877 Controlled Release Tablet

Kowa Company, Ltd.

NCT06009393 COMPLETED

Evaluate the Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia

Beijing Suncadia Pharmaceuticals Co., Ltd

NCT05753436 COMPLETED

Curcumin's Effect on Diabetic Patients With Atherosclerotic Cardiovascular Risk

Ain Shams University

NCT05694260 COMPLETED

A Clinical Study in Children With Heterozygous Familial Hypercholesterolemia (HeFH) Aged 6 to 17 Treated Once Daily With Bempedoic Acid Oral Dosing (CLEAR Path 1)

Esperion Therapeutics, Inc.

NCT04761861 WITHDRAWN

Vildagliptin for Treatment of Antipsychotic-induced Dyslipidemia

Sadat City University

NCT05256654 COMPLETED

A Study of LY3561774 in Participants With Mixed Dyslipidemia

Eli Lilly and Company

NCT04164888 COMPLETED

Phase 2a Study to Assess CIVI 007 in Patients on a Background of Statin Therapy

Civi Biopharma, Inc.

NCT04823611 COMPLETED

A Study of AZD8233 in Participants With Dyslipidemia.

AstraZeneca

NCT05261126 COMPLETED

A Study of the Efficacy and Safety of Enclitide Chloride (MK-0616 Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-008)

Merck Sharp & Dohme LLC

NCT05421078 COMPLETED

A Dose-Finding Study in Japanese Patients to Evaluate the Effect of Obicetrapib as an Adjunct to Stable Statin Therapy.

NewAmsterdam Pharma

NCT04753606 COMPLETED

Randomized Study of Obicetrapib as an Adjunct to Statin Therapy

NewAmsterdam Pharma

NCT05266586 COMPLETED

Study to Evaluate the Effect of Obicetrapib in Combination With Ezetimibe as an Adjunct to HIS Therapy

NewAmsterdam Pharma

NCT04666298 COMPLETED

Study of Efficacy and Safety of Inclisiran in Japanese Participants With High Cardiovascular Risk and Elevated LDL-C

Novartis Pharmaceuticals

NCT04784442 COMPLETED

A Dose-finding Trial of ETC-1002(Bempedoic Acid) in Patients With Hypercholesterolemia

Otsuka Pharmaceutical Co., Ltd.

NCT04770389 COMPLETED

Randomized Study of Obicetrapib in Combination With Ezetimibe

NewAmsterdam Pharma

NCT05795517 COMPLETED

Study of HSK31679 in Subjects With Hypercholesterolemia With Nonalcoholic Fatty Liver Disease（NAFLD）

Haisco Pharmaceutical Group Co., Ltd.

NCT03857256 COMPLETED

Compare the Efficacy and Safety of Beta-Glucan as Add-On to Statin in Subjects With Hyperlipidemia.

Montreal Heart Institute

NCT04447820 COMPLETED

Study to Investigate the Efficacy and Pharmacokinetic Profile of K-877-ER Compared to K-877-IR

Kowa Research Institute, Inc.

NCT03815812 COMPLETED

Multiple Ascending Dose Study of PCSK-9 Inhibitor (IBI306) in Chinese Patients With Hypercholesterolemia

Innovent Biologics (Suzhou) Co. Ltd.

NCT02651675 TERMINATED

A Gene Therapy Study for Homozygous Familial Hypercholesterolemia (HoFH)

REGENXBIO Inc.

NCT04846231 COMPLETED

Supplements, Placebo, or Rosuvastatin Study

The Cleveland Clinic

NCT03060577 COMPLETED

An Extension Trial of Inclisiran in Participants With Cardiovascular Disease and High Cholesterol

Novartis Pharmaceuticals

NCT02681055 COMPLETED

Open-Label Study To Evaluate MN-001 on HDL & Triglyceride in NASH & NAFLD Subjects

MediciNova

NCT03381287 COMPLETED

A Multiple Ascending Dose Study of HTD1801 in Adults With Hypercholesterolemia

HighTide Biopharma Pty Ltd

NCT03933293 COMPLETED

A Study to Evaluate the Safety and Efficacy of the PCSK9 Inhibitor AK102 in Patients With HoFH

Akeso

NCT04173793 COMPLETED

A Study of PCSK9 Inhibitor AK102 in Patients With Heterozygous Familial Hypercholesterolemia (HeFH)

Akeso

NCT04358432 COMPLETED

A Study of PCSK9 Inhibitor AK102 in Patients With Hypercholesterolemia

Akeso

NCT04173403 COMPLETED

A Long-term Study of AK102 in Patients With Hypercholesterolemia

Akeso

NCT03175367 COMPLETED

Study of Evinacumab (REGN1500) in Participants With Persistent Hypercholesterolemia

Regeneron Pharmaceuticals

NCT03097107 SUSPENDED

Evaluate the Safety and Efficacy of Saroglitazar Mg in Patients With Fasting Triglyceride ≥500 mg/dL and ≤1500 mg/dL

Zydus Therapeutics Inc.

NCT03960541 TERMINATED

Efprezimod Alfa (CD24Fc, MK-7110) Administration to Decrease Low-Density Lipoprotein (LDL) and Inflammation in Human Immunodeficiency Virus (HIV) Patients (CALIBER) (MK-7110-003)

Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

NCT03944109 COMPLETED

The Safety, Tolerability and Efficacy of Multiple Subcutaneous Injections of SHR-1209 in Subjects With Hyperlipidemia

Jiangsu HengRui Medicine Co., Ltd.

NCT04516291 COMPLETED

A Dose-Ranging Study With Vupanorsen (TRANSLATE-TIMI 70)

Pfizer

NCT03611010 COMPLETED

Dose-ranging Efficacy and Pharmacokinetics Study of Intravenous Atorvastatin in Hypercholesterolemic Patients

Cumberland Pharmaceuticals

NCT04573218 COMPLETED

Supplementation of Oil Palm Phenolics to Improve Lipid Profile in Subjects With Minor Hyperlipidaemia

Isa Naina Mohamed

NCT03718286 COMPLETED

Effects of Acute, Rapid Lowering of LDL Cholesterol With Alirocumab in Patients With STEMI Undergoing Primary PCI

Population Health Research Institute

NCT03847974 COMPLETED

Open-Label Extension to Evaluate the Longer Term Efficacy and Safety of LIB003

LIB Therapeutics LLC

NCT05028699 COMPLETED

Evaluation of Common Bean Baked Snack Consumption on Blood Lipids in Overweight People With Altered Blood Lipid Levels

Centro Universitario de Ciencias de la Salud, Mexico

NCT03110848 COMPLETED

Effects of Atorvastatin in Graves' Orbitopathy (GO)

University of Pisa

NCT04069715 COMPLETED

The Effect of Farlong® NotoGinseng™ (Ginseng Plus®) on Cholesterol and Blood Pressure

LongStar HealthPro, Inc. DBA Farlong Pharmaceutical

NCT02278471 COMPLETED

The SCCS Polypill Pilot Trial

Vanderbilt University

NCT02927184 COMPLETED

Safety and Tolerability of VK2809 in Patients With Primary Hypercholesterolemia and Non-Alcoholic Fatty Liver Disease

Viking Therapeutics, Inc.

NCT02963311 COMPLETED

A Study of ALN-PCSSC in Participants With Homozygous Familial Hypercholesterolemia (HoFH)

The Medicines Company

NCT03051100 COMPLETED

Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg, Ezetimibe 10mg, and Atorvastatin 20 mg Triplet Therapy in Patients With Elevated LDL-C

Esperion Therapeutics, Inc.

NCT03193047 COMPLETED

Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg When Added to PCSK9 Inhibitor Therapy

Esperion Therapeutics, Inc.

NCT02719028 COMPLETED

Trial of Antroquinonol in Patients With Hypercholesterolemia and Hyperlipidemia

Golden Biotechnology Corporation

NCT02265952 COMPLETED

Study of REGN1500 in Participants With Homozygous Familial Hypercholesterolemia (HoFH)

Regeneron Pharmaceuticals

NCT03401580 WITHDRAWN

Efficacy of Fixed-doses of Antihypertensive and Statin Drugs

EMS

NCT02597127 COMPLETED

Trial to Evaluate the Effect of ALN-PCSSC Treatment on Low Density Lipoprotein Cholesterol (LDL-C)

The Medicines Company

NCT02659397 COMPLETED

A Study Of Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mg

Esperion Therapeutics, Inc.

NCT02775448 TERMINATED

Dose-response Study of Carduus Marianus in Centesimal Scale for Dyslipidemia in Climacteric Overweighed or Obese Women.

Hospital Nacional Homeopático, Mexico

NCT03455777 WITHDRAWN

Study of AKCEA-ANGPTL3-LRX (ISIS 703802) in Patients With Homozygous Familial Hypercholesterolemia (HoFH)

Akcea Therapeutics

NCT02977065 COMPLETED

To Assess the Safety, Efficacy and Tolerability of CKD-519, Administered With HMG-CoA Reductase Inhibitors

Chong Kun Dang Pharmaceutical

NCT02989753 COMPLETED

Effects of Two Herbal Dietary Supplements on Lipid Metabolism in Moderate Hypercholesterolemia and Hypertriglyceridemia

Valbiotis

NCT03216811 COMPLETED

Nutraceutical in Cardiovascular Primary Prevention

University Hospital of Ferrara

NCT02608697 COMPLETED

A Study to Assess the Safety and Efficacy of CAT-2054 in Combination With Atorvastatin in Patients With Hypercholesterolemia

Catabasis Pharmaceuticals

NCT03027336 COMPLETED

Efficacy and Tolerability of the Nutraceutical Formulation Coleosoma in Dyslipidemic Subjects

Azienda Ospedaliero-Universitaria di Parma

NCT02472535 COMPLETED

Study to Evaluate the Effects of MBX-8025 in Patients With HoFH

Gilead Sciences

NCT02541201 COMPLETED

The Effect of a Plant Sterols-Enriched Low-Fat Milk on Lipid Profile in Healthy Southern Chinese (COME-PASS)

The University of Hong Kong

NCT07428473 NOT YET RECRUITING

A Study of STX-1150 in Participants With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)

Monash University

NCT06980428 RECRUITING

A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels, and Participants With Dyslipidemia

AstraZeneca

NCT06164730 RECRUITING

A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease

Verve Therapeutics, Inc.

NCT07229118 RECRUITING

A Study to Evaluate COR-1004 in Adult Volunteers.

Corsera Health

NCT07347678 NOT YET RECRUITING

Phase 1a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RN5681 in Healthy Volunteers

Ikaria Bioscience Pty Ltd

NCT07322016 NOT YET RECRUITING

A Study of HRS-1301 Tablets in Healthy Subjects and Those With Impaired Kidney Function

Shandong Suncadia Medicine Co., Ltd.

NCT07312773 NOT YET RECRUITING

A Study to Evaluate the Pharmacokinetic Interaction and the Safety of AD-231A and AD-231B and AD-231C

Addpharma Inc.

NCT06784349 ACTIVE NOT RECRUITING

ALN-APOC3 in Adult Participants With Dyslipidemia

Regeneron Pharmaceuticals

NCT07152873 NOT YET RECRUITING

A Study to Compare to PK Characteristics and Safety Profiles Between AD-117 and AD-117A

Addpharma Inc.

NCT06451770 RECRUITING

Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia

Verve Therapeutics, Inc.

NCT07162441 RECRUITING

A Two-arm, Open-label, Single-sequence, Multiple-dose, Cross-over Study to Evaluate the Pharmacokinetic Interaction and the Safety of UIC202502 and UIC202505 in Healthy Adult Volunteers

Korea United Pharm. Inc.

NCT06732154 ACTIVE NOT RECRUITING

A Phase I Clinical Study of a Single Subcutaneous Injection of HRS-5632 in Healthy Subjects

Fujian Shengdi Pharmaceutical Co., Ltd.

NCT07074236 NOT YET RECRUITING

Pharmacokinetics and Pharmacodynamics Study

Qilu Pharmaceutical Co., Ltd.

NCT06837077 ACTIVE NOT RECRUITING

Study of SHR-1209 Administered by Single-site or Multiple-site Subcutaneous Injections in Healthy Volunteers

Jiangsu HengRui Medicine Co., Ltd.

NCT06933459 ACTIVE NOT RECRUITING

To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C714 and C714R in Healthy Adults

AJU Pharm Co., Ltd.

NCT07001787 NOT YET RECRUITING

A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HS-10510 in Healthy Subjects

Jiangsu Hansoh Pharmaceutical Co., Ltd.

NCT06976489 NOT YET RECRUITING

The Food Effect on PK Characteristics and Safety Profiles of PA-111

Addpharma Inc.

NCT06932705 RECRUITING

A Study to Compare to PK Characteristics and Safety Profiles Between PA-111 and PA-111A

Addpharma Inc.

NCT06504043 ENROLLING BY INVITATION

A Study on Evaluating the Safety of HST101 in Healthy Chinese Participants

Hasten Biopharmaceutical Co., Ltd.

NCT06669429 RECRUITING

A Study on the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RS-C1001 Tablets in Chinese Healthy Subjects

Peking University First Hospital

NCT06578676 RECRUITING

To Evaluate the Safety and Pharmacokinetic Interaction Between HODO-22251 and HODO-22252 in Healthy Adults

Hyundai Pharm

NCT05043181 NOT YET RECRUITING

Exosome-based Nanoplatform for Ldlr mRNA Delivery in FH

Tang-Du Hospital

NCT07412080 COMPLETED

EDP167 in Healthy Volunteers and Subjects With Mild Dyslipidemia

Eddingpharm (Zhuhai) Co., Ltd.

NCT07097831 COMPLETED

A Clinical Trial of HRS-1301 on the Pharmacokinetics of Rosuvastatin Calcium Tablets in Healthy Subjects

Shandong Suncadia Medicine Co., Ltd.

NCT07319559 COMPLETED

Clinical Trial to Evaluate the Safety, Pharmacokinetic Characteristics of DW5124 and DW5124-R, and the Effect of Food on DW5124 in Healthy Adult Volunteers

Daewon Pharmaceutical Co., Ltd.

NCT03747224 COMPLETED

Study of ARO-ANG3 in Healthy Volunteers and in Dyslipidemic Patients

Arrowhead Pharmaceuticals

NCT06615284 COMPLETED

A Study of Atorvo+™ in Healthy Adult Participants

Indication Bioscience LLC

NCT06857253 COMPLETED

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-1301 in Healthy Subjects

Shandong Suncadia Medicine Co., Ltd.

NCT06742853 COMPLETED

A Study to Investigate the Pharmacokinetics, Safety, Tolerability, and Efficacy of AZD0780 With Ezetimibe Combinations in Healthy Adults With Elevated LDL-C.

AstraZeneca

NCT06541457 COMPLETED

A Study on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-7249 Injection in Healthy Subjects

Fujian Shengdi Pharmaceutical Co., Ltd.

NCT05851066 COMPLETED

A VSA003 Phase 1 Study in Chinese Adult Healthy Volunteers

Visirna Therapeutics HK Limited

NCT06889012 COMPLETED

A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1018 and Coadministration of BR1018A and BR1018B in Healthy Adult Volunteers

Boryung Pharmaceutical Co., Ltd

NCT04640012 COMPLETED

Ascending-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics of DC371739 Single-Dose Treatment in Healthy Subjects

Guangzhou JOYO Pharma Co., Ltd

NCT06931327 COMPLETED

To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C711 in Healthy Adults

AJU Pharm Co., Ltd.

NCT06758661 COMPLETED

Clinical Study to Evaluate Drug-drug Interaction and Safety After Co-administration of D352 and D794 in Healthy Adult Volunteers

Chong Kun Dang Pharmaceutical

NCT05398029 COMPLETED

A Study of VERVE-101 in Patients With Familial Hypercholesterolemia and Cardiovascular Disease

Verve Therapeutics, Inc.

NCT05787002 COMPLETED

A Study to Assess the Effect of AZD0780 on the Pharmacokinetics of Rosuvastatin.

AstraZeneca

NCT04774003 COMPLETED

Study of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inclisiran in Chinese Participants With Elevated Serum LDL-C

Novartis Pharmaceuticals

NCT06007651 TERMINATED

A Study of LY3885125 in Participants With Dyslipidemia or Non-Alcoholic Fatty Liver Disease (NAFLD)

Eli Lilly and Company

NCT06655311 COMPLETED

A Study of Enlicitide Chloride (MK-0616) in Healthy Participants and Participants Taking Statins (MK-0616-012)

Merck Sharp & Dohme LLC

NCT04692025 COMPLETED

Study to Evaluate the Effect of Food on the Pharmacokinetics of ASC41 in Healthy Volunteers

Gannex Pharma Co., Ltd.

NCT04686994 COMPLETED

Study to Evaluate the Safety and Efficacy of ASC41 in Overweight and Obese Subjects

Gannex Pharma Co., Ltd.

NCT06592339 COMPLETED

A Study of MK-0616 in Healthy Adult Participants (MK-0616-009)

Merck Sharp & Dohme LLC

NCT04606602 COMPLETED

Study to Investigate Safety, Tolerability, PK and PD Response of SLN360 in Subjects With Elevated Lipoprotein(a)

Silence Therapeutics plc

NCT05703282 COMPLETED

A Study to Assess the Safety and Pharmacokinetics of AD-104-A

Addpharma Inc.

NCT05384262 COMPLETED

A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD0780 in Healthy Subjects

AstraZeneca

NCT06475872 COMPLETED

Study to Evaluate the Bioequivalence of "Crecheck Tablet 2.5 mg (Rosuvastatin Calcium)" and "Crestor Tablet 5 mg (Rosuvastatin Calcium)" in Healthy Adult Subjects

Hanlim Pharm. Co., Ltd.

NCT06184269 COMPLETED

A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1017-1" and Co-administration of "BR1017-1A" and "BR1017-1B"

Boryung Pharmaceutical Co., Ltd

NCT06088017 COMPLETED

A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391(2)

Chong Kun Dang Pharmaceutical

NCT06112678 COMPLETED

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(6)

Chong Kun Dang Pharmaceutical

NCT06225635 COMPLETED

A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Ezerosu Tab

Shin Poong Pharmaceutical Co. Ltd.

NCT05749861 COMPLETED

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(5)

Chong Kun Dang Pharmaceutical

NCT04660370 COMPLETED

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348

Chong Kun Dang Pharmaceutical

NCT04883658 COMPLETED

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(2)

Chong Kun Dang Pharmaceutical

NCT05733455 COMPLETED

Effect of Alpelisib in Healthy Volunteers

Columbia University

NCT05698043 COMPLETED

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(5) 80/20/10mg

Chong Kun Dang Pharmaceutical

NCT05634447 COMPLETED

A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391

Chong Kun Dang Pharmaceutical

NCT05335044 COMPLETED

Study to Evaluate the Safety and Pharmacokinetics of CKD-331

Chong Kun Dang Pharmaceutical

NCT05192356 COMPLETED

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(3)

Chong Kun Dang Pharmaceutical

NCT05549401 COMPLETED

Clinical Trial to Evaluate the Tolerability and the Pharmacokinetics of CKD-348

Chong Kun Dang Pharmaceutical

NCT05460364 COMPLETED

A Study to Evaluate the Pharmacokinetic Interaction and Safety Between BR1018-1 and BR1018-2 in Healthy Adult Subjects

Boryung Pharmaceutical Co., Ltd

NCT05681247 COMPLETED

Bioavailability and Bioequivalence of Ezetimibe Tablets in Healthy Subjects

The Affiliated Hospital of Qingdao University

NCT05370950 COMPLETED

Study of Bioavailability, Pharmacodynamics and Safety of SHR-1209 Administered by Single Subcutaneous Injection at Different Sites in Healthy Volunteers

Jiangsu HengRui Medicine Co., Ltd.

NCT05552495 COMPLETED

Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-386 in Healthy Volunteers Under Fasting Conditions

Chong Kun Dang Pharmaceutical

NCT04922424 WITHDRAWN

Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men

Yale University

NCT05245084 COMPLETED

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(3) 80/20/10mg

Chong Kun Dang Pharmaceutical

NCT04644809 COMPLETED

A Study of LY3561774 in Participants With Dyslipidemia

Eli Lilly and Company

NCT05202405 COMPLETED

A Study to Evaluate the Safety and Pharmacokinetics of AD-221 Compared to Coadministration of AD-221A and AD-221B

Addpharma Inc.

NCT04927221 COMPLETED

Multiple Ascending Dose Study to Evaluate the Safety, Tolerability of DC371739 Treatment in Hypercholesterolemic

Guangzhou JOYO Pharma Co., Ltd

NCT04987970 COMPLETED

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2) 80/20/10mg

Chong Kun Dang Pharmaceutical

NCT03885661 COMPLETED

Vascepa to Accelerate Lipoprotein Uptake and Elimination

University of Pennsylvania

NCT04673864 COMPLETED

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386

Chong Kun Dang Pharmaceutical

NCT04694989 COMPLETED

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2)

Chong Kun Dang Pharmaceutical

NCT04155645 COMPLETED

To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD8233 After Multiple Dose Administration in Subjects With Dyslipidemia

AstraZeneca

NCT02714569 COMPLETED

A Study to Evaluate LY3202328 in Overweight Healthy Participants and Dyslipidemia

Eli Lilly and Company

NCT04874142 COMPLETED

Phase 1 to Evaluate the Safety and Pharmacokinetic Durg-drug Interaction of YYC506-T and YYC506-A

Yooyoung Pharmaceutical Co., Ltd.

NCT04052594 COMPLETED

A Study of LY3475766 in Healthy Participants

Eli Lilly and Company

NCT04755894 COMPLETED

HDDO-1756 Bio Equivalence Study

Hyundai Pharmaceutical Co., LTD.

NCT04587206 COMPLETED

A Clinical Trial to Evaluate the Pharmacokinetics and Tolerability of CKD-348

Chong Kun Dang Pharmaceutical

NCT02374047 COMPLETED

A 2-Part, Phase 1, Single and Multiple Ascending Dose Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of CAT-2054 in Healthy Subjects

Catabasis Pharmaceuticals

NCT03593785 COMPLETED

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD8233 in Healthy Male Subjects With Increased Elevated LDL-C Levels.

AstraZeneca

NCT03366688 COMPLETED

Single Ascending Dose Study of PCSK-9 Inhibitor (IBI306) in Healthy Subjects.

Innovent Biologics (Suzhou) Co. Ltd.

NCT04055168 TERMINATED

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD6615 in Healthy Subjects

AstraZeneca

NCT02709850 COMPLETED

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS ANGPTL3-LRx in Healthy Volunteers With Elevated Triglycerides and Participants With Familial Hypercholesterolemia

Ionis Pharmaceuticals, Inc.

NCT03427710 COMPLETED

A First In Human Study to Assess CiVi007 in Subjects With an Elevated LDL-Cholesterol Level

Civi Biopharma, Inc.

NCT04258865 COMPLETED

A Clinical Trial to Compare the Pharmacokinetics and Tolerability of CKD-348

Chong Kun Dang Pharmaceutical

NCT04354987 COMPLETED

Compare the Pharmacokinetics and Safety of CKD-391

Chong Kun Dang Pharmaceutical

NCT04019743 COMPLETED

Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of CKD-333 in Healthy Volunteers

Chong Kun Dang Pharmaceutical

NCT04197817 COMPLETED

A Single Dose Escalation Study of PCSK9 Inhibitor (JS002) in Health Subjects

Shanghai Junshi Bioscience Co., Ltd.

NCT03577275 COMPLETED

A Study to Evaluate the Effects of NST-4016 on QT/Corrected QT (QTc) Interval

NorthSea Therapeutics B.V.

NCT03707899 COMPLETED

The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Adult Volunteers Volunteers

Jeil Pharmaceutical Co., Ltd.

NCT03632668 COMPLETED

Evaluating the Pharmacokinetic Interaction Between AD-2071 and AD-2072

Addpharma Inc.

NCT03690778 COMPLETED

The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers.

Jeil Pharmaceutical Co., Ltd.

NCT03116516 COMPLETED

Clinical Trial to Compare the Safety and Pharmacokinetics of YHP1604 in Comparison to the Co-administration of Telmisartan/Amlodipine and Rosuvastatin

Yuhan Corporation

NCT03793985 COMPLETED

Compare the Pharmacokinetics and Safety of CKD-391 With Co-administration of D086 and D337

Chong Kun Dang Pharmaceutical

NCT03659149 COMPLETED

Pharmacokinetics and Safety Profile of CKD-333

Chong Kun Dang Pharmaceutical

NCT03586037 COMPLETED

Evaluating the Pharmacokinetic Interaction Between AD-2011 and AD-2012

Addpharma Inc.

NCT03609606 COMPLETED

A Study to Investigate Drug Interaction Between D326, D337, and D013 in Healthy Male Subjects

Chong Kun Dang Pharmaceutical

NCT02654899 TERMINATED

Single Dose Study of PF-06815345 in Healthy Subjects

Pfizer

NCT03657472 COMPLETED

Bioequivalence Study of CJ-30061 in Healthy Male Volunteers

HK inno.N Corporation

NCT03545438 COMPLETED

Study to Evaluate the Safety, PK, and Pharmacodynamics of LIB003

LIB Therapeutics LLC

NCT02982798 COMPLETED

The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers

Jeil Pharmaceutical Co., Ltd.

NCT02449187 COMPLETED

Investigate the Effect of Food on the Pharmacokinetics of JLP-1310 in Healthy Male Volunteers

Jeil Pharmaceutical Co., Ltd.

NCT03461081 COMPLETED

Drug-drug Interaction Following Oral Administration of Telmisartan/Amlodipine and Atorvastatin in Healthy Adult Volunteers

Jeil Pharmaceutical Co., Ltd.

NCT02994745 COMPLETED

A Clinical Trial to Evaluate the Pharmacokinetics and Safety/Tolerability of Fimasartan and Atorvastatin in Healthy Male Volunteers.

Boryung Pharmaceutical Co., Ltd

NCT03382756 COMPLETED

A Clinical Trial to Assess the Effects of Food on the Bioavailability of CKD-337

Chong Kun Dang Pharmaceutical

NCT03247140 COMPLETED

The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Male Volunteers Volunteers

Jeil Pharmaceutical Co., Ltd.

NCT03346187 COMPLETED

A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337

Chong Kun Dang Pharmaceutical

NCT02979015 COMPLETED

A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous (SC) Administered Alirocumab in Healthy Chinese Subjects

Sanofi

NCT03235362 COMPLETED

A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between YHR1705 and YHR1706

Yuhan Corporation

NCT02508896 COMPLETED

Study Assessing Safety, Immunogenicity and LDLc -Lowering Activity of 2 PCSK9 Targeting AFFITOPE Vaccines in Healthy Subjects

Affiris AG

NCT02995720 COMPLETED

A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin

Boryung Pharmaceutical Co., Ltd

NCT03017950 COMPLETED

Pharmacokinetic Drug-drug Interaction of CKD-330 and D086

Chong Kun Dang Pharmaceutical

NCT02753504 COMPLETED

Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519

Chong Kun Dang Pharmaceutical

NCT03175835 COMPLETED

Study to Evaluate the Drug Interaction Between CKD-519 and Rosuvastatin in Healthy Male Subjects

Chong Kun Dang Pharmaceutical

NCT03210649 COMPLETED

Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519

Chong Kun Dang Pharmaceutical

NCT02951962 COMPLETED

A Study to Investigate Pharmacokinetic Drug Interaction and Safety of Telmisartan/Amlodipine and Rosuvastatin

Yuhan Corporation

NCT02608242 TERMINATED

PK Study of YH22189 FDC Compared to Combination of Telmisartan/Amlodipine and Rosuvastatin

Yuhan Corporation

NCT03009474 COMPLETED

Pharmacokinetics Study of CJ-30060 After Single Dose Administration in Health Male Volunteers

HK inno.N Corporation

NCT02941796 COMPLETED

Pharmacokinetics and Safety of HCP1105 and Co-administration of HGP0918, HGP0816 in Healthy Male Volunteers

Hanmi Pharmaceutical Company Limited

NCT02667223 TERMINATED

Pharmacokinetic and Pharmacodynamic Study of Bococizumab Alone and When Combined With Recombinant Human Hyaluronidase

Pfizer

NCT02933658 COMPLETED

Study of Multiple Oral Dosing to Evaluate the Safety and the Pharmacokinetic Drug-drug Interaction of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers

Daewon Pharmaceutical Co., Ltd.

NCT02408055 COMPLETED

ADME Study in Healthy Male Subjects With TA-8995

Xention Ltd

NCT02651753 COMPLETED

A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337

Chong Kun Dang Pharmaceutical

NCT02387619 COMPLETED

The Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan/Amlodipine

Jeil Pharmaceutical Co., Ltd.

NCT02566187 COMPLETED

A Study to Compare the Pharmacokinetics of Fimasartan/Atorvastatin Combination Tablet

Boryung Pharmaceutical Co., Ltd

NCT02569814 COMPLETED

A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin

Boryung Pharmaceutical Co., Ltd

NCT02623868 COMPLETED

Study to Assess PK/PD Character, Safety/Tolerability of CKD-519 New Formulation in Healthy Male Subject.

Chong Kun Dang Pharmaceutical

NCT02634034 COMPLETED

A Comparison Study to Evaluate the Pharmacokinetics and Safety of NK-104-CR in Healthy Adult Volunteers

Kowa Research Institute, Inc.

NCT02484482 COMPLETED

Study to Investigate the Effect of Food on the Pharmacokinetics/Pharmacodynamics and Safety of CKD-519(CKD-519 FDI)

Chong Kun Dang Pharmaceutical

NCT07442630 ACTIVE NOT RECRUITING

Long-term Comparison of Pitavastatin/Ezetimibe and Pitavastatin in Patients With Hypercholesterolemia and Elevated Triglycerides

JW Pharmaceutical

NCT07314775 NOT YET RECRUITING

Yangxin Dawayimixike Honey Paste for Carotid Atherosclerotic Plaque With Dyslipidemia: A Randomized Controlled Clinical Study

Xinjiang Uygur Pharmaceutical Co., Ltd.

NCT05749874 ACTIVE NOT RECRUITING

Effects of Berberine on Preventing Cardiovascular Disease and Diabetes Mellitus

China National Center for Cardiovascular Diseases

NCT07255820 NOT YET RECRUITING

Dual vs Triple Lipid-Lowering Therapy in Type 2 Diabetes Mellitus Patients With Elevated LDL Cholesterol

Bahria University

NCT05910476 ACTIVE NOT RECRUITING

Comparative Study of Rosuvastatin/Ezetimib 20/10 mg and Atovastatin/Ezetimib 40/10 mg (TOLERANT Trial)

Yonsei University

NCT06789432 RECRUITING

Efficacy and Safety of Atorvastatin and Ezetimibe (10/10mg) Fixed Dose Combination Versus Atorvastatin (20mg) Monotherapy in Bangladeshi Population

Dr. Md. Alimur Reza

NCT06186037 RECRUITING

Clinical Comparison of Low-dose Rosuvastatin Plus Ezetimibe Combination Therapy and High-dose Rosuvastatin Monotherapy in Patients With Minimal to Intermediate Coronary Artery Disease Without Percutaneous Coronary Intervention

Saint Vincent's Hospital, Korea

NCT06386419 ACTIVE NOT RECRUITING

A Clinical Study to Evaluate the Safety and Effectiveness of Inclisiran Sodium in Indian Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

Novartis Pharmaceuticals

NCT05537948 ACTIVE NOT RECRUITING

Efficacy and Safety of Pitavastatin and PCSK9 Inhibitors in Liver Transplant Patients

National Medical Research Center for Therapy and Preventive Medicine

NCT06784557 RECRUITING

Effect of Ezetimibe on Gut Microbiota

Yonsei University

NCT05845424 RECRUITING

High-intensity Statin and Ezetimibe Therapy for Asymptomatic Patients With Positive Coronary Calcium

Samsung Medical Center

NCT06586684 NOT YET RECRUITING

Effect of Small Interfering RNA Inclisiran on Carotid Plaques As Assessed by Carotid Ultrasound

First Affiliated Hospital of Xinjiang Medical University

NCT06463561 RECRUITING

CPAP Effect on Lipid Profile and Hyperuricemia in Patients With Dyslipidemia and Moderate-severe Obstructive Sleep Apnea

Hospital Universitario La Paz

NCT05365438 RECRUITING

Atmeg (Atorvastatin and Omega-3 Combination) and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia

Seoul National University Bundang Hospital

NCT05365425 RECRUITING

Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia

Seoul National University Bundang Hospital

NCT06381947 NOT YET RECRUITING

Efficacy and Safety of Bempedoic Acid in Association With Anti-PCSK9 and Ezetimibe in Statin-intolerant Patients

University of Salerno

NCT06431763 COMPLETED

A Study to Investigate LDL-cholesterol Lowering With Inclisiran Compared to Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease.

Novartis Pharmaceuticals

NCT06925100 COMPLETED

A Study to Investigate the Effectiveness and Safety of Bempedoic Acid in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia in Taiwan

Daiichi Sankyo

NCT04700436 COMPLETED

Efficacy and Safety of EzetimiBe/Rosuvastatin in Diabetic Dislipidemia With Hypertriglyceridaemia

Seoul National University Hospital

NCT03988101 COMPLETED

Role of Statin in Venous Dysfunction in Patients With Venous Thromboembolism Event

Yonsei University

NCT05192941 COMPLETED

Study of Efficacy, Safety, Tolerability and Quality of Life of Inclisiran (KJX839) vs Placebo, on Top of Ongoing Individually Optimized Lipid-lowering Therapy, in Participants With Hypercholesterolemia

Novartis Pharmaceuticals

NCT04638400 TERMINATED

Anti-inflammatory Effects of Simvastatin

paresh Dandona

NCT02668016 COMPLETED

Self-Assessment Method for Statin Side-effects Or Nocebo

Imperial College London

NCT04073134 TERMINATED

The CHORAL Flow Study

Imperial College London

NCT04120753 COMPLETED

Clinical Trial to Evaluate the Efficacy and Safety of OLOMAX Tab

Daewoong Pharmaceutical Co. LTD.

NCT03403374 COMPLETED

Safety and Tolerability of Repatha® (Evolocumab) in Indian Participants With Homozygous Familial Hypercholesterolemia

Amgen

NCT06359353 COMPLETED

Effect of Pitavastatin on Bone

Seoul National University Bundang Hospital

NCT06231459 COMPLETED

Expression of Pro- and Anti-inflammatory Cytokines During Anti-PCSK9 in Familial Hypercholesterolemia

Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado

NCT03951207 COMPLETED

Rosuvastatin/Amlodipine vs Atorvastatin/Amlodipine in Hypertension Patient With Dyslipidemia

Yuhan Corporation

NCT04510844 WITHDRAWN

Evolocumab In Advanced Chronic Kidney Disease Trial

NYU Langone Health

NCT05467384 COMPLETED

Effect of Amlodipine on the Lipid Profile of Newly Diagnosed Hypertensive Patients

Ayub Teaching Hospital

NCT05465278 COMPLETED

Alirocumab and Plaque Burden In Familial Hypercholesterolaemia

Fundación Hipercolesterolemia Familiar

NCT03847506 COMPLETED

Evaluate Efficacy and Safety of Ezetimibe/Rosuvastatin and Candesartan Cilexetil/Amlodipine Besylate Combination Tablets

HK inno.N Corporation

NCT03906539 COMPLETED

Effect of Virgin Coconut Oil (VCO) on Cardiometabolic Parameters in Patients With Dyslipidemia

All India Institute of Medical Sciences, Bhubaneswar

NCT03550287 COMPLETED

Evaluation of the Effect of a Shiitake Extract on Lipid Profile in Subjects With Moderate Hyperlipidemia

Instituto de Investigación Hospital Universitario La Paz

NCT05095480 COMPLETED

Effect of Red Yeast Rice Beside Statin on Lipid Profile

Shiraz University of Medical Sciences

NCT03434613 COMPLETED

Phase IV Study to Evaluate the Effects of Statin Monotherapy or Statin / Ezetimibe Combination Therapy on Hepatic Steatosis in Patients With Hyperlipidemia and Nonalcoholic Fatty Liver Disease

Yonsei University

NCT03694197 TERMINATED

Long Term Safety Study of PRALUENT

Regeneron Pharmaceuticals

NCT02957682 COMPLETED

Evaluating Effect of the Study Drug Praluent (Alirocumab) on Neurocognitive Function When Compared to Placebo

Regeneron Pharmaceuticals

NCT03267329 COMPLETED

Duowell® vs. Telmisartan Monotherapy in Mild Dyslipidemia Patients With Hypertension

Yuhan Corporation

NCT02437084 COMPLETED

Relationship Between Insulin Resistance and Statin Induced Type 2 Diabetes, and Integrative Personal Omics Profiling

Stanford University

NCT03331666 TERMINATED

Impact of LDL-cholesterol Lowering on Platelet Activation

Columbia University

NCT02772640 COMPLETED

Effectiveness of Treatment of Hypercholesterolemia With Rosuvastatin and Ezetimibe

Collegium Medicum w Bydgoszczy

NCT04511000 COMPLETED

Clinical Trial to to Compare of the Efficacy and Safety of Lipilou® 20 mg and Lipilou® 10 mg

Chong Kun Dang Pharmaceutical

NCT03074630 COMPLETED

Dapagliflozin and Cholesterol Metabolism in Type 2 Diabetes (DM2)

Amsterdam UMC, location VUmc

NCT03559309 TERMINATED

Investigating the Effects of Lipid-therapy Intensification With Alirocumab on Endothelial Function, Carotid Arteries, Lipoprotein Particle Subfractions, Inflammation and Post-prandial Lipemia

Medical University of Graz

NCT03217409 COMPLETED

A Study to Compare Rosuvastatin/Ezetimibe and Rosuvastatin in Patients With Diabetes Mellitus and Hypercholesterolemia

Yuhan Corporation

NCT02984982 COMPLETED

Evaluation of Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients Hospitalized for Acute Coronary Syndrome With Hypercholesterolemia

Sanofi

NCT02938949 COMPLETED

Alirocumab in Patients With Acute Myocardial Infarction

Virginia Commonwealth University

NCT03604471 COMPLETED

Lipid-lowering Therapy Individualization

Université Catholique de Louvain

NCT04061824 COMPLETED

Clinical Study to Evaluate Adherence Improvement Fixed-dose Combination of Olostar Tab. in Patients With Hypertension and Dyslipidemia

Yonsei University

NCT03446261 COMPLETED

Rosuvastatin/Ezetimibe vs Rosuvastatin in Korean Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia

Yuhan Corporation

NCT03047538 WITHDRAWN

Fixed Combination for Lipid and Blood Pressure Control

Charles University, Czech Republic

NCT03750760 WITHDRAWN

Early Alirocumab to Reduce LDL-C in Myocardial Infarction

Imperial College London

NCT03949374 COMPLETED

Clinical Trial to Evaluate Efficacy and Safety of ROVASRO 10mg Versus CRESTOR 10mg in Hypercholesterolemic Patients

Yonsei University

NCT02824432 COMPLETED

Exploratory Study of the Effect of Omega-3-acid Ethyl Esters (TAK-085) on Vascular Endothelial Function in Patients With Hyperlipidemia by Flow Mediated Dilation

Takeda

NCT02839902 COMPLETED

Exploratory Study of the Effects of Omega-3-acid Ethyl Esters on the Lipid and Lipoprotein Profile in the Blood

Takeda

NCT02499185 TERMINATED

Study Evaluating Novel Biomarkers of AKI (Acute Kidney Injury) in Post-operative Patients

Universitair Ziekenhuis Brussel

NCT02642159 COMPLETED

Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia)

Sanofi

NCT03470376 COMPLETED

NUtraceutical TReatment for hYpercholesterolemia in HIV-infected Patients

University Of Perugia

NCT02913170 COMPLETED

Nattokinase Supplementation and Hemostatic Factors

Yonsei University

NCT02644109 COMPLETED

Effect On Serum Cholesterol Of Dairy Products With Addition Of Esterified Phytosterols

University of Chile

Data: ClinicalTrials.gov